Sudden cardiac arrest (SCA) causes ~20% of all deaths in Europe. SCA is lethal within minutes if left untreated and survival rates are presently only 5-20%. Therefore, there is a large medical need to improve SCA prevention and treatment.
Designing effective individualised prevention and treatment strategies require knowledge on genetic and environmental risk factors. So far, these efforts have been hampered by the lack of sufficiently large study cohorts of SCA patients with detailed information. Obtaining SCA patient samples is challenging as the condition happens suddenly and unexpectedly.
In this project, leading European scientific teams which have created large relevant population cohorts, mostly dedicated to SCA research, join forces to fully exploit available data towards improving SCA management.
This will be done through :
To achieve the project aim, the following sub-objectives are defined:
In this project, the large international scientific societies/associations European Heart Rhythm Association (EHRA) and the European Resuscitation Council (ERC),
are involved as project partners in order to translate the outcomes
into European clinical practice for the prevention of SCA, and European
infrastructures to improve survival after SCA.
Read the ESCAPE-NET flyer here
|Participant Number||Participant Organisation Name||Country|
|1 ( Coordinator )||Academic Medical Center (AMC)||NL|
|2||University of Copenhagen (UC-REGIONH)||DK|
|3||Unisersite Paris Descartes, Inserm (UP)||FR|
|4||University of Pavia ( UPAV)||IT|
|5||IRCCS Istituto Auxologico Italiano (AUXO)||IT|
|6||VU University Medical Center||NL|
|7||European Heart Rhythm Association (EHRA) a registered branch of the European Society of Cardiology (ESC)||FR|
|8||BC Platforms (BCP)||FI|
|9||Karolinska Institute (KI)||SW|
|10||Emergency Medical Services of the Hradec Kralove Region (EMS)||CZ|
|11||European Rescucitation Council (ERC)||BE|
|12||Istituto di Ricerche Farmacologiche "Mario Negri" (IRFMN)||IT|
|14||Fundacio Institut Mar d'Investigacions Mediques (IMIM)||ES|
|16||Helmholtz Zentrum Munchen (HZM)||DE|
Duration: 60 months